Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001437749-24-028152
Filing Date
2024-08-30
Accepted
2024-08-30 17:01:33
Documents
18

Document Format Files

Seq Description Document Type Size
1 FORM DEFR14A opk20240828_defr14a.htm   iXBRL DEFR14A 128060
6 capvnetincrs.jpg GRAPHIC 100921
7 capvrevrs.jpg GRAPHIC 101385
8 capvtsrrs.jpg GRAPHIC 95865
  Complete submission text file 0001437749-24-028152.txt   1378259

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA opk-20231231.xsd EX-101.SCH 2727
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20231231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20231231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20231231_pre.xml EX-101.PRE 714
20 EXTRACTED XBRL INSTANCE DOCUMENT opk20240828_defr14a_htm.xml XML 122176
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-33528 | Film No.: 241270927
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)